Full Text (PDF)
Original Article

Safety and Efficacy of Dexmedetomidine as an Adjuvant to Hyperbaric Bupivacaine: A Randomised Double-Blind Controlled Study

Anand Acharya , S.V. Ravikanth1 , P. Ravi Kumar2 , Anand Acharya3

Author Information

Licence:




Indian Journal of Anesthesia and Analgesia 6(3):p 763-768, May-June 2019. | DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6319.10

How Cite This Article:

S.V. Ravikanth, P. Ravi kumar, Anand Acharya. Safety and Efficacy of Dexmedetomidine as an Adjuvant to Hyperbaric Bupivacaine: A Randomised Double-Blind Controlled Study. Indian J Anesth Analg. 2019;6(3):763-768.


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

 Background: Various adjuvants are co-administrated with local anaesthetic agent to improve the speed of onset of block, duration of analgesia and can decrease the dose of local anaesthetic agent. As the dose of local anaesthetic decreases, its adverse drug reaction also used to decrease specifically Bupivacaine. Present study has been designed to evaluate the, efficacy and safety of dexmedetomidine as an adjuvant to bupivacaine in spinal anaesthesia. Method: This is a randomised, double blind, prospective comparative study conducted in the department of anaesthesia, Based on inclusion and exclusion criteria 72 patients were enrolled for this study. These patients were randomly allocated in to two groups Group B and Group BD. Sensory parameters like, onset of sensory block; total duration of sensory block was recorded using pin prick method. Motor block was assessed with modified Bromage score. Time for onset and duration of motor block was recorded. Result: Mean time required for the onset of sensory block in group B was 3.24 + 1.34min and in Group B, it was 2.42 + 0.84 min. This difference is statistically significant. The P value was 0.006. The mean duration of sensory block was 181.07 + 20.8 min in group B and 263.6+38.8 min in group BD. This difference was significant statically (p=0.00001). The mean time for onset of motor block was 8.31 + 1.84 min in group B and 7.94 + 32.0 in group BD. This difference is not significant statistically. The p value was 0.1428. Discussion and Conclusion: From present study we conclude that 5 microgram dexmedetomidine as an adjuvant to hyperbaric bupivacaine prolong the duration of sensory and motor block. It provides good quality of analgesia, haemodynamic stability and prolongs post-operative analgesia.


References

No records found.


About this article


Cite this article

S.V. Ravikanth, P. Ravi kumar, Anand Acharya. Safety and Efficacy of Dexmedetomidine as an Adjuvant to Hyperbaric Bupivacaine: A Randomised Double-Blind Controlled Study. Indian J Anesth Analg. 2019;6(3):763-768.


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6319.10

Keywords

Dexmedetomidine; Adjuvant; Hyperbaric Bupivacaine; Spinal Block

Article Level Metrics

Last Updated

Monday 13 July 2026, 11:12:42 (IST)


5651

Accesses

3
678
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share